Drugs / Ventolin Evohaler
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06644924 | Feb → Jun 2025 | asthma | AstraZeneca | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ventolin Evohaler | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06644924 ↗ |
| Route | Inhaled | “Drug: Treatment (Ventolin Evohaler) Randomized participants will receive a single-dose (2 inhalations)” NCT06644924 ↗ |